What should be used for baselines against which to compare treatments' effectiveness?

Psychotherapy Research

Volumn 19, Issue 3, 2009, Pages 358-367

  Krause, Merton S ^a   Lutz, Wolfgang ^a  

^a UNIVERSITY OF TRIER   (Germany)

Author keywords

Bona fide treatments; Feasible control groups; Lower baselines; Lower bound baseline; Natural course; Upper bound baseline

Indexed keywords

ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PSYCHOLOGY; FEASIBILITY STUDY; HUMAN; INTERMETHOD COMPARISON; MEDICAL ETHICS; MENTAL HEALTH; PRIORITY JOURNAL; PSYCHOTHERAPY;

HUMANS; MENTAL DISORDERS; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 70549092798     PISSN: 10503307     EISSN: 14684381     Source Type: Journal    
DOI: 10.1080/10503300902926539     Document Type: Article

References (45)

1. Basham, R. B. (1986). Scientific and practical advantages of comparative design in psychotherapy outcome research. Journal of Consulting and Clinical Psychology, 54, 88-94.
2. Baskin, T. W., Tierney, S. C., Minami, T., & Wampold, B. E. (2003). Establishing specificity in psychotherapy: A meta-analysis of structural equivalence of placebo controls. Journal of Consulting and Clinical Psychology, 71, 973 979.
3. Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J. (2005). Neurobiological mechanisms of the placebo effect. Journal of Neuroscience, 25, 10390-10402.
4. Borkovec, T. D., & Costello, E. (1993). Efficacy of applied relaxation and cognitive-behavioral therapy in the treatment of generalized anxiety disorder. Journal of Consulting and Clinical Psychology, 61, 611-619.
5. Borkovec, T. D., & Miranda, J. (1999). Between-group psychotherapy outcome research and basic science. Journal of Clinical Psychology, 55, 147-158.
6. Chambless, D. L., & Ollendick, T. H. (2001). Empirically supported psychological interventions: Controversies and evidence. Annual Review of Psychology, 52, 685-716.
7. Critelli, J. W., & Neumann, K. F. (1984). The placebo: Conceptual analysis of a construct in transition. American Psychologist, 39, 32-39.
8. Crits-Christoph, P. (1997). Control groups in psychotherapy research revisited. Prevention & Treatment, 1, Article ID 2c. Retrieved from http://www.journals.apa.org/prevention/volume1.
9. Dehue, T. (2000). From deception trials to control reagents: The introduction of the control group about a century ago. American Psychologist, 55, 264-268.
10. Freedman, B. (1987). Equipoise and the ethics of clinical research. New England Journal of Medicine, 317, 141-145.
11. Greenwood, J. D. (1997). Placebo control treatments and the evaluation of psychotherapy: A reply to Grunbaum and Erwin. Philosophy of Science, 64, 497-510.
12. Hollon, S. D., & DeRubeis, R. J. (1981). Placebo-psychotherapy combinations: Inappropriate representations of psychotherapy in drug-psychotherapy comparative trials. Psychological Bulletin, 90,467-477.
13. Howard, K. I., Krause, M. S., & Orlinsky, D. E. (1986). The attrition dilemma. Journal of Consulting and Clinical Psychology, 54, 106-110.
14. Howard, K. I., Krause, M. S., Saunders, S. M., & Kopta, S. M. (1997). Trials and tribulations in the meta-analysis of treatment differences: Comment on Wampold et al. (1997). Psychological Bulletin, 122, 221-225.
15. Howard, K. I., Krause, M. S., & Vessey, J. (1994). Analyzing clinical trial data: The problem of outcome overlap. Psychotherapy, 31, 302-307.
16. Hsu, L. M. (1989). Random sampling, randomization, and equivalence of contrasted groups in psychotherapy outcome research. Journal of Consulting and Clinical Psychology, 57, 131-137.
17. Jacobson, N. S., & Truax, P. (1991). Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. Journal of Consulting and Clinical Psychology, 59, 12-19.
18. Kazdin, A. E. (1999). The meanings and measurement of clinical significance. Journal of Consulting and Clinical Psychology, 67, 332-339.
19. Kirsch, I. (2005). Placebo psychotherapy: Synonym or oxymoron. Journal of Clinical Psychology, 61, 791-803.
20. Kirsch, I., & Sapirstein, G. (1998). Listening to Prozac but hearing placebo: A meta-analysis of antidepressant medication. Prevention & Treatment, 1(2), Article ID 2a. Retrieved from http://www.journals.apa.org/prevention/volume1.
21. Klein, D. F. (1997). Control groups in pharmacotherapy and psychotherapy evaluations. Prevention & Treatment, 1(1), Article ID 1a. Retrieved from http://www.journals.apa.org/prevention/volume1.
22. Kraemer, H. C. (2008). Toward non-parametric and clinically meaningful moderators and mediators. Statistics in Medicine, 27, 1679-1692.
23. Krause, M. S. (2005). How the psychotherapy research community must work toward measurement validity and why. Journal of Clinical Psychology, 61, 269-283.
24. Krause, M. S., & Howard, K. I. (1976). Evaluation in the public interest. Community Mental Health Journal, 5, 291-300.
25. Krause, M. S., & Howard, K. I. (2003). What random assignment does and does not do. Journal of Clinical Psychology, 59, 751-766.
26. Krause, M. S., Howard, K. I., & Lutz, W. (1998). Exploring individual change. Journal of Consulting and Clinical Psychology, 66, 838-845.
27. Krause, M. S., & Lutz, W. (2006). How we really ought to be comparing treatments effectiveness for clinical purposes. Psychotherapy, 43, 359-361.
28. Krause, M. S., & Lutz, W. (2009). Process transforms inputs to determine outcomes: Therapists are responsible for managing process. Clinical Psychology: Science and Practice, 16, 73-81.
29. Krause, M. S., Lutz, W., & Saunders, S. M. (2007). Empirically certified treatments or therapists: The issue of separability. Psychotherapy, 44, 347-353.
30. Lutz, W., Leach, C., Barkham, M., Lucock, M., Stiles, W. B., Evans, C., et al. (2005). Predicting change for individual psychotherapy clients based on their nearest neighbors. Journal of Consulting and Clinical Psychology, 73, 904-913.
31. Lutz, W., Saunders, S. M., Leon, S. C., Martinovich, Z., Kosfelder, J., Schulte, D., et al. (2006). Empirical and clinical useful decision making in psychotherapy: Differential predictions with treatment response models. Psychological Assessment, 18, 133-141.
32. Manheim, L. M. (1998). Health services research clinical trials: Issues in the evaluation of economic costs and benefits. Controlled Clinical Trials, 19, 149-158.
33. Maraun, M. D. (1998). Measurement as a normative practice: Implications of Wittgenstein's philosophy for measurement in psychology. Theory & Psychology, 8, 435-461.
34. Mattocks, K. M., & Horwitz, R. I. (2000). Placebos, active control groups, and the unpredictability paradox. Biological Psychiatry, 47, 693-698.
35. Miller, G. A., & Chapman, J. P. (2001). Misunderstanding analysis of covariance. Journal of Abnormal Psychology, 110, 40-48.
36. Moras, K. (1997). Toward a core battery for treatment efficacy research on mood disorders. In H. H. Strupp, L. M. Horowitz & M. J. Lambert (Eds), Measuring patient changes in mood, anxiety, and personality disorders: Toward a core battery (pp. 301-338). Washington, DC,(1997).: American Psychological Association.
37. Ogle, B. M., Lambert, M. J., & Masters, K. S. (1996). Assessing outcome in clinical practice. Boston: Allyn & Bacon.
38. Rosenberger, W. F., & Lachin, J. M. (2002). Randomization in clinical trials: Theory and practice. New York: Wiley.
39. Rosnow, R. L., & Rosenthal, R. (1997). People studying people: Artifacts and ethics in behavioral research. New York: Freeman.
40. Stiles, W. B. (2007). Theory-building case studies of counselling and psychotherapy. Counselling and Psychotherapy Research, 7, 122-127.
41. Strupp, H. H., Horowitz, L. M., & Lambert, M. J. (Eds.). (1997). Measuring patient changes in mood, anxiety, and personality disorders: Toward a core battery. Washington, DC: American Psychological Association.
42. Wampold, B. E. (1997). Methodological problems in identifying efficacious psychotherapies. Psychotherapy Research, 7, 21-43.
43. Wampold, B. E. (2001). The great psychotherapy debate: Models, methods, and findings. Mahwah, NJ: Erlbaum.
44. Yates, B. T. (1994). Toward the incorporation of costs, cost-effectiveness analysis, and cost-benefit analysis into clinical research. Journal of Consulting and Clinical Psychology, 62, 729-736.
45. Zimmerman, M., McGlinchey, J. B., Posternak, M. A., Friedman, M., Attiullah, M., & Boerescu, D. (2006). How should remission from depression be defined? The depressed patient's perspective. American Journal of Psychiatry, 163, 148-150.